Giuseppina Brancaccio

6PUBLICATIONS
43CO-AUTHORS
Haematological tumoursGene and molecular therapyGenomicsHaematologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 09, 2026
Direct Acting Antivirals Before Surgical Resection of HCV Related HCC: Impact on Tumour Pathology and Outcomes.

|Oct 06, 2023
Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 + .

Massimo Bellato, Marco Cappellato, Francesca Longhin

|Oct 05, 2022
Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants.

Claudia Del Vecchio, Bethan Cracknell Daniels, Giuseppina Brancaccio

|Dec 17, 2021
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.

Loreta A Kondili, Monica Monti, Maria Giovanna Quaranta

|Jan 29, 2020
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting-authors' reply.

Giuseppina Brancaccio, Giovanni B Gaeta

|Feb 23, 2019
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.

Giuseppina Brancaccio, Massimo Fasano, Adriano Grossi

Pageof 1